QQ客服 官方微博 反馈留言

	Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials
	Xiao, Zheng; Wang, Cheng-qiong; Zhou, Ming-hua; Li, Na-na; Liu, Shi-yu; He, Yue-juan; Wang, Yu-zhi; Feng, Ji-hong; Yao, Xin-sheng; Chen, Ling
刊名	INTERNATIONAL IMMUNOPHARMACOLOGY
	2018
卷号	61
关键词	Cytokine-induced killer cells (CIK cells) Lung cancer Radiotherapy Cellular immunity Radiotherapy-related toxicity Meta-analysis
ISSN号	1567-5769
DOI	10.1016/j.intimp.2018.06.012
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4235436
专题	武汉大学
推荐引用方式 GB/T 7714	Xiao, Zheng,Wang, Cheng-qiong,Zhou, Ming-hua,et al. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2018,61.
APA	Xiao, Zheng.,Wang, Cheng-qiong.,Zhou, Ming-hua.,Li, Na-na.,Liu, Shi-yu.,...&Ding, Jie.(2018).Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.INTERNATIONAL IMMUNOPHARMACOLOGY,61.
MLA	Xiao, Zheng,et al."Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials".INTERNATIONAL IMMUNOPHARMACOLOGY 61(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。